Bowen Hanes & Co’s Amgen AMGN Stock Holding History

Bowen Hanes & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,632	Closed	-$500K	–	137
2019 Q1	$500K	Sell	2,632 -6,868	-72%	-$1.31M	0.02%	118
2018 Q4	$1.85M	Buy	+9,500	New	+$1.85M	0.09%	85

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bowen Hanes & Co's AMGN Position: Q2 2019 in Review

Bowen Hanes & Co sold out of Amgen (AMGN) in Q2 2019, closing a stake of 2,632 shares — an estimated $500K sold.

Bowen Hanes & Co first reported a position in AMGN in Q4 2018 and held it in 2 quarters. The position peaked at $1.85M in Q4 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Bowen Hanes & Co reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Bowen Hanes & Co sold 2,632 Amgen shares in Q2 2019, an estimated $500K.
Bowen Hanes & Co first reported a position in Amgen in Q4 2018 and held it in 2 quarters.
Bowen Hanes & Co's Amgen position peaked at $1.85M in Q4 2018.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Bowen Hanes & Co's 13F filing for Q2 2019, filed 13 Aug 2019.